Ohana is pioneering a new frontier in reproductive medicine.  Built upon a world-leading understanding of sperm biology, Ohana has created a best-in-class proprietary platform with broad applications across reproductive medicine. 

Ohana is developing field defining new  products to improve sperm quality and function to address infertility, prevent inherited disease, and produce a long-acting, reversible, non-hormonal male contraceptive. 

Ohana was founded by Flagship Pioneering and is located in Cambridge, MA.